Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.
Watson JA. et al, (2025), Antimicrob Agents Chemother
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Pukrittayakamee S. et al, (2024), eLife, 12
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Reference spectrophotometric values for glucose-6-phosphate dehydrogenase activity in two-to six-month-old infants on the Thailand-Myanmar border
Bancone G. et al, (2024), Wellcome Open Research, 7, 273 - 273
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Immunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera.
Wongsawat M. et al, (2024), Malaria journal, 23
Challenges of Plasmodium vivax and Plasmodium knowlesi co-infection.
Charoenwisedsil R. et al, (2023), Journal of travel medicine, 30
In Vitro Tracking of Sporozoites via Fluorescence Imaging and MRI Using Multifunctional Micelles.
Assawapanumat W. et al, (2023), ACS applied bio materials, 6, 5324 - 5332
Study on the dielectrophoretic characteristics of malaria-infected red blood cells.
Panklang N. et al, (2023), Electrophoresis, 44, 1837 - 1846
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Intestinal injury and the gut microbiota in patients with Plasmodium falciparum malaria.
Sriboonvorakul N. et al, (2023), PLoS pathogens, 19
Identification and function of a novel human memory-like NK cell population expressing CD160 in melioidosis
Preechanukul A. et al, (2023), iScience, 26, 107234 - 107234
Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
Yipsirimetee A. et al, (2023), Antimicrobial agents and chemotherapy, 67
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
Abdel Hamid MM. et al, (2023), Wellcome Open Research, 8, 22 - 22
Differential Effect of Extracellular Vesicles Derived from Plasmodium falciparum-Infected Red Blood Cells on Monocyte Polarization.
Khowawisetsut L. et al, (2023), International journal of molecular sciences, 24
The prognostic and diagnostic value of intraleukocytic malaria pigment in patients with severe falciparum malaria
Srinamon K. et al, (2022), Nature Communications, 13
Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand.
Win KN. et al, (2022), Malaria journal, 21